EIF4E and neoplasm: Mechanistically, tumor derived EV‐packaged eIF4E significantly enhances the expression of 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme A reductase (HMGCR), driving the synthesis and secretion of cholesterol.